SFM
ARRY

Sphera Funds Management’s Array Biopharma Inc ARRY Stock Holding History

Sphera Funds Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,500
Closed -$3.42M – 145
2015
Q3 		$3.42M Buy
+7,500
New +$44.5K 0.44% 47

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sphera Funds Management's ARRY Position: Q1 2019 in Review

Sphera Funds Management sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 125,000 shares — an estimated $1.78M sold.

Sphera Funds Management first reported a position in ARRY in Q2 2014 and held it in 17 quarters. The position peaked at $7.91M in Q4 2016. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • Sphera Funds Management reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
  • Sphera Funds Management sold 125,000 Array Biopharma Inc shares in Q1 2019, an estimated $1.78M.
  • Sphera Funds Management first reported a position in Array Biopharma Inc in Q2 2014 and held it in 17 quarters.
  • Sphera Funds Management's Array Biopharma Inc position peaked at $7.91M in Q4 2016.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.